Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study.
Casale P, Saita A, Lazzeri M, Lughezzani G, Hurle R, Fasulo V, Mondellini GM, Paciotti M, Domanico L, Lista G, Maffei D, Monari M, Motta L, Bini V, Ceriotti F, Guazzoni G, Buffi NM. Casale P, et al. Among authors: paciotti m. Minerva Urol Nefrol. 2019 Jun;71(3):273-279. doi: 10.23736/S0393-2249.19.03279-X. Epub 2019 Jan 28. Minerva Urol Nefrol. 2019. PMID: 30700081 Free article.
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS.
Hurle R, Lazzeri M, Saita A, Naselli A, Guarneri A, Buffi NM, Lughezzani G, Fasulo V, Mondellini GM, Paciotti M, Domanico L, Peschechera R, Benetti A, Zandegiacomo S, Lista G, Pasini L, Guazzoni G, Casale P. Hurle R, et al. Among authors: paciotti m. Minerva Urol Nefrol. 2019 Aug;71(4):406-412. doi: 10.23736/S0393-2249.19.03254-5. Epub 2019 May 28. Minerva Urol Nefrol. 2019. PMID: 31144485 Free article.
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer.
Lughezzani G, Saita A, Lazzeri M, Paciotti M, Maffei D, Lista G, Hurle R, Buffi NM, Guazzoni G, Casale P. Lughezzani G, et al. Among authors: paciotti m. Eur Urol Oncol. 2019 May;2(3):329-332. doi: 10.1016/j.euo.2018.10.001. Epub 2018 Oct 25. Eur Urol Oncol. 2019. PMID: 31200848
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project.
Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, Fasulo V, Paciotti M, Domanico L, Bevilacqua G, Maffei D, Diana P, Frego N, Sandri MT, Maura F, Morenghi E, Buffi NM, Guazzoni G, Lazzeri M. Hurle R, et al. Among authors: paciotti m. World J Urol. 2020 Sep;38(9):2215-2220. doi: 10.1007/s00345-019-03002-3. Epub 2019 Nov 5. World J Urol. 2020. PMID: 31691083
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis.
Klotz L, Lughezzani G, Maffei D, Sánchez A, Pereira JG, Staerman F, Cash H, Luger F, Lopez L, Sanchez-Salas R, Abouassaly R, Shore ND, Eure G, Paciotti M, Astobieta A, Wiemer L, Hofbauer S, Heckmann R, Gusenleitner A, Kaar J, Mayr C, Loidl W, Rouffilange J, Gaston R, Cathelineau X, Klein E. Klotz L, et al. Among authors: paciotti m. Can Urol Assoc J. 2021 Jan;15(1):E11-E16. doi: 10.5489/cuaj.6712. Can Urol Assoc J. 2021. PMID: 32701437 Free PMC article.
103 results